Literature DB >> 10523035

Complete hypogonadotropic hypogonadism associated with a novel inactivating mutation of the gonadotropin-releasing hormone receptor.

F P Pralong1, F Gomez, E Castillo, S Cotecchia, L Abuin, M L Aubert, L Portmann, R C Gaillard.   

Abstract

In this study, we describe a patient with a phenotype of complete hypogonadotropic hypogonadism who presented primary failure of pulsatile GnRH therapy, but responded to exogenous gonadotropin administration. This patient bore a novel point mutation (T for A) at codon 168 of the gene encoding the GnRH receptor (GnRH-R), resulting in a serine to arginine change in the fourth transmembrane domain of the receptor. This novel mutation was present in the homozygous state in the patient, whereas it was in the heterozygous state in both phenotypically normal parents. When introduced into the complementary DNA coding for the GnRH-R, this mutation resulted in the complete loss of the receptor-mediated signaling response to GnRH. In conclusion, we report the first mutation of the GnRH-R gene that can induce a total loss of function of this receptor and is associated with a phenotype of complete hypogonadotropic hypogonadism.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10523035     DOI: 10.1210/jcem.84.10.6042

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

Review 1.  Neonatal gonadotropin therapy in male congenital hypogonadotropic hypogonadism.

Authors:  Claire Bouvattier; Luigi Maione; Jérôme Bouligand; Catherine Dodé; Anne Guiochon-Mantel; Jacques Young
Journal:  Nat Rev Endocrinol       Date:  2011-10-18       Impact factor: 43.330

Review 2.  G protein-coupled receptors involved in GnRH regulation: molecular insights from human disease.

Authors:  Sekoni D Noel; Ursula B Kaiser
Journal:  Mol Cell Endocrinol       Date:  2011-06-29       Impact factor: 4.102

Review 3.  Genotype and phenotype of patients with gonadotropin-releasing hormone receptor mutations.

Authors:  Hyung-Goo Kim; Jennifer Pedersen-White; Balasubramanian Bhagavath; Lawrence C Layman
Journal:  Front Horm Res       Date:  2010-04-08       Impact factor: 2.606

4.  Computational Analysis of Missense Variants of G Protein-Coupled Receptors Involved in the Neuroendocrine Regulation of Reproduction.

Authors:  Le Min; Min Nie; Anna Zhang; Junping Wen; Sekoni D Noel; Vivian Lee; Rona S Carroll; Ursula B Kaiser
Journal:  Neuroendocrinology       Date:  2015-06-18       Impact factor: 4.914

5.  Evolved regulation of gonadotropin-releasing hormone receptor cell surface expression.

Authors:  Jo Ann Janovick; Alfredo Ulloa-Aguirre; P Michael Conn
Journal:  Endocrine       Date:  2003-12       Impact factor: 3.633

Review 6.  GnRH, anosmia and hypogonadotropic hypogonadism--where are we?

Authors:  Paolo E Forni; Susan Wray
Journal:  Front Neuroendocrinol       Date:  2014-10-13       Impact factor: 8.606

7.  Genetics of isolated hypogonadotropic hypogonadism: role of GnRH receptor and other genes.

Authors:  Karges Beate; Neulen Joseph; de Roux Nicolas; Karges Wolfram
Journal:  Int J Endocrinol       Date:  2011-12-21       Impact factor: 3.257

8.  Congenital hypogonadotropic hypogonadism due to GnRH receptor mutations in three brothers reveal sites affecting conformation and coupling.

Authors:  Javier A Tello; Claire L Newton; Jerome Bouligand; Anne Guiochon-Mantel; Robert P Millar; Jacques Young
Journal:  PLoS One       Date:  2012-06-05       Impact factor: 3.240

9.  A TAC3 Missense Variant in a Domestic Shorthair Cat with Testicular Hypoplasia and Persistent Primary Dentition.

Authors:  Petra Hug; Patricia Kern; Vidhya Jagannathan; Tosso Leeb
Journal:  Genes (Basel)       Date:  2019-10-14       Impact factor: 4.096

10.  A case report of congenital idiopathic hypogonadotropic hypogonadism caused by novel mutation of GNRHR gene.

Authors:  Liping Wang; Weisheng Lin; Xiaohong Li; Lijuan Zhang; Kai Wang; Xiaoli Cui; Shanmei Tang; Guangguang Fang; Yan Tan; Xuelai Wang; Chuan Chen; Chuanchun Yang; Huiru Tang
Journal:  Medicine (Baltimore)       Date:  2021-02-05       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.